The Fragility of Statistically Significant Results in Randomized Clinical Trials for COVID-19

Authors:

Abstract
Since December 2019, the number of people with COVID-19 has surged worldwide.1 Information about this newly discovered infectious disease has been widely reported in both traditional and social media, resulting in global awareness of a previously unknown respiratory infection and increased public perception of risk. This emergency situation has pressured researchers to conduct randomized clinical trials (RCTs) immediately, at various study scales and of varied quality.2 Regardless of the scale and quality of RCTs, the results of each received attention from the general public and health care researchers, via different media, and people alternated between optimism and despair based on the individual findings of these trials.3
Keywords

This publication has 68 references indexed in Scilit: